Reynders McVeigh Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$24.2M Buy
2025
Q1
$25.9M Buy
2024
Q4
$21M Buy
2024
Q3
$22.7M Buy
2024
Q2
$19.9M Buy
2024
Q1
$12.8M Buy
2023
Q4
$6.57M Buy
2023
Q3
$4.89M Buy
2023
Q2
$3.3M Buy
2023
Q1
$1.25M Buy
2022
Q4
$412K Buy